Introduction
Amitriptyline, a tricyclic antidepressant, is commonly prescribed for patients with depression who undergo electroconvulsive therapy (ECT) with general anesthesia. In addition, amitriptyline is now widely used for the treatment of chronic and neuropathic pain conditions [1, 2] . To date, amitriptyline has been reported to have multiple pharmacological actions such as inhibition of the neural reuptake of noradrenaline, serotonin, and adenosine; blockade of α-adrenergic, cholinergic, and N-methyl-D-aspartate receptors; modulation of opioid receptor-mediated function; and inhibition of ion channel activities [3, 4] . Thus, it would be important for anesthesiologists to understand the multiple pharmacological actions of amitriptyline on organ functions, as well as its known interactions with various other drugs, such as adrenergic agonists.
Previous studies [5, 6] have reported that amitriptyline signifi cantly infl uences airway smooth muscle reactivity. In asthmatics, amitriptyline improved clinical status, as well as reducing their medication requirements [5, 6] . In an in vivo study of guinea pigs, amitriptyline counteracted the bronchoconstrictor actions of histamine, serotonin, and acetylcholine (ACh) [5] . However, the precise mechanisms behind the inhibitory action of amitriptyline on airway smooth muscle have not yet been fully clarifi ed.
The lung is innervated by both the sympathetic and parasympathetic nervous systems, which entail the activation of adrenergic and muscarinic receptors, respectively, located on both airway smooth muscle and autonomic nerves [7] . Specifi cally, activation of the postjunctional M 3 muscarinic receptor leads to airway constriction, while activation of the prejuctional M 2 muscarinic receptor results in airway relaxation. In addition, activation of the prejunctional and/or postjunctional β 2 -adrenergic receptors could lead to airway relaxation. Thus, ACh (a parasympathetic neurotrans-mitter) and noradrenaline (a sympathetic neurotransmitter) would both play a crucial role in the control of airway smooth muscle tone or reactivity.
In the present study with isolated rat trachea, we fi rst examined the effects of amitriptyline on the contractile response to both exogenously applied and endogenously released (in response to electrical fi eld stimulation [EFS]) ACh, and found that amitriptyline attenuated the contractile response to both exogenously applied and endogenously released ACh. Therefore, we next attempted to clarify the mechanisms behind the amitriptyline-induced airway relaxation, utilizing various pharmacological tools, including guanethidine (a sympathetic suppressor), calyculin A (a myosin light chain [MLC] phosphatase inhibitor), and sphingosylphosphorylcholine (SPC; a Rho-kinase activator). Specifically, guanethidine, calyculin A, and SPC were used to examine the possible involvement of the noradrenalinereuptake mechanism, the Ca 2+ -calmodulin-myosin light chain kinase (MLCK) pathway, and the Rhokinase pathway, respectively, in the amitriptylineinduced airway relaxation. In addition, inositol monophosphate (IP 1 ) accumulation was measured to examine whether amitriptyline attenuated the contractile response to ACh by inhibiting phosphatidylinositol (PI) metabolism.
Materials and methods
The studies were conducted under guidelines approved by the Animal Care Committee of Nagasaki University School of Medicine. Fifty-two male Wistar rats (Charles River, Yokohama, Japan) weighing 250-350 g were used for the experiments. The rats were anesthetized with pentobarbital (50 mg·kg −1 , i.p.), and their tracheas were rapidly isolated. Isometric tensions were measured using an isometric transducer and changes in isometric force were recorded using a MacLab system (Milford, MA, USA). The resting tension was periodically adjusted to 1.0 g during the equilibration period. The rings were washed every 15 min and re-equilibrated to baseline tension for 60 min (time 0).
Isometric tension measurement

Electrical fi eld stimulation
Electrical stimuli were generated by an SEN-7203 stimulator (Nihon Kohden, Tokyo, Japan) and applied between two platinum electrodes. Pulses of 2 ms and 50 V were delivered at a frequency of 25 Hz for 10 s, and a 15-min recovery period was allowed between successive trains.
Measurement of IP 1 accumulation
A technique modifi ed from that of Brown et al. [8] H] myo-inositol was then added to each tube (fi nal concentration of 0.1 μM in a 300-μl incubation volume). The tubes were then fl ushed with O 2 95%/ CO 2 5%, capped, set in a shaking bath at 37°C, and incubated for 30 min (time 0). Amitriptyline, 10 μM, or none was added at time 0; 15 min later, ACh, 10 μM, was added. After 60 min, the reaction was stopped with 940 μl of chloroform/methanol (1 : 2 v/v). Chloroform and water were then added (300 μl each) and the phases were separated by centrifugation at 90 g for 5 min. The 
Experimental protocols
In the fi rst series of experiments, we examined the effects of amitriptyline on the contractile response to exogenously applied ACh. Specifi cally, amitriptyline (1 μM-1 mM) was cumulatively applied to the rings precontracted with ACh (10 μM).
In the second series of experiments, we attempted to examine the effects of amitriptyline on the contractile response to endogenously released ACh, utilizing the contractile response to EFS. In preliminary experiments, both tetrodotoxin (TTX; an Na channel blocker) [9] and 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP; an M 3 -cholinergic receptor antagonist) [10] inhibited the EFS response, with values for the concentrations required to exert 50% inhibition (IC 50 ) of 20 ± 8 nM and 3.0 ± 0.8 nM, respectively; these agents eliminated the EFS response at 100 nM and 30 nM, respectively ( Fig. 1 ). However, prazosin (an α 1 -adrenergic blocker [11] ), at 0.1-10 μM, and capsaicin (a neuronal desensitizer depleting calcitonin gene related peptide [CGRP] from the nerve terminals [12] ), at 0.1-10 μM, did not infl uence the EFS response (P > 0.05, n = 6, data not shown). These results suggest that the EFS response was mediated exclusively by ACh released from the nerve terminals, but not by α 1 -adrenergic receptors or CGRF. Also, in this series of experiments, amitriptyline (1-100 μM) was cumulatively applied to the rings precontracted with EFS.
In the above experiments, amitriptyline signifi cantly inhibited the contractile response to ACh or EFS. Therefore, in the following experiments, we attempted to clarify the mechanisms underlying the amitriptylineinduced tracheal relaxation, utilizing various pharmacological tools. Specifi cally, in the third series of experiments, in order to investigate the possibility that amitriptyline causes tracheal relaxation by inhibiting the reuptake of noradrenaline into the sympathetic nerves, we examined the effects of amitriptyline (1-100 μM) on the contractile response to EFS after treatment with guanethidine (10 μM), which depletes noradrenaline from the sympathetic nerves [13] .
In the fourth series of experiments, in order to investigate the possibility that amitriptyline causes tracheal relaxation by inhibiting the Ca 2+ -calmodulin-MLCK pathway, we examined the effects of amitriptyline on the contractile response to calyculin A (an MLC phosphatase inhibitor [14] ). Specifi cally, amitriptyline (10 μM-1 mM) was applied to the rings for 15 min before stimulation with calyculin A (1 μM), because the contractile response to calyculin-A decreased significantly with time in the preliminary study.
In the fi fth series of experiments, in order to investigate the possibility that amitriptyline causes tracheal relaxation by inhibiting the Rho-kinase pathway, we examined the effects of amitriptyline on the contractile response to SPC (a Rho-kinase activator [15] ). Specifically, amitriptyline (10 μM-1 mM) was cumulatively applied to the rings precontracted with SPC (10 μM).
In the fi nal series of experiments, utilizing the method modifi ed from Brown et al. [8] detailed above, we examined the effects of amitriptyline on ACh-indued IP 1 accumulation. Amitriptyline (10 μM) or none was applied to the slices before stimulation with ACh (10 μM).
Data analyses
Data were expressed as means ± SD. Concentrationeffect curves were fi tted by nonlinear regression (GraphPad Prism; GraphPad, San Diego, CA, USA). The results for the guanethidine data were analyzed by twoway analysis of variance (ANOVA). The interaction was statistically signifi cant, and therefore differences between the control and guanethidine groups were analyzed by one-way ANOVA. The other results were also analyzed by one-way ANOVA followed by Bonferroni's multiple comparison test. A value of P < 0.05 was considered statistically signifi cant.
Results
Amitriptyline inhibited (P < 0.05) the contractile response to ACh (10 μM) in a concentration-dependent manner, with an IC 50 value of 4.3 ± 1.3 μM (n = 6; Fig. 2B ). In addition, amitriptyline inhibited (P < 0.05) the contractile response to EFS in a concentration-dependent manner, with an IC 50 value of 3.2 ± 1.6 μM (n = 9; Fig. 3 ). No signifi cant difference was observed between the IC 50 value for inhibition of the ACh response and that for inhibition of the EFS response.
Treatment with guanethidine (10 μM) caused (P < 0.05) a modest leftward shift of the concentrationresponse curve for the inhibitory action of amitriptyline on the contractile response to EFS (Fig. 3) . The IC 50 Amitriptyline (mM) Fig. 3 . The effects of amitriptyline on electrical fi eld stimulation (EFS)-induced contraction of rat tracheal rings in the absence (control; closed squares) or presence of guanethidine (open triangles; mean ± SD, n = 9; number of rats, N = 10). *P < 0.05; ***P < 0.001 vs control. EFS, 25 Hz; guanethidine, 10 μM. The concentrations of amitriptyline required to exert 50% inhibition (IC 50 ) of the EFS-induced contractions were 3.2 ± 1.6 and 1.3 ± 0.4 μM in the absence and presence of guanethidine, respectively value for the amitriptyline-induced inhibition of EFS response (1.3 ± 0.4 μM; n = 9) in the guanethidinetreated rings was lower (P < 0.05) than that in the control rings (3.2 ± 1.6 μM; n = 9). Amitriptyline inhibited (P < 0.05) the contractile response to calyculin A (1 μM) in a concentrationdependent manner, with an IC 50 value of 256.4 ± 106.4 μM (n = 7-11; Fig. 4) , and almost eliminated it at 300 μM.
Amitriptyline inhibited (P < 0.05) the contractile response to SPC (10 μM) in a concentration-dependent manner, with an IC 50 value of 98.2 ± 21.8 μM (n = 8; Fig. 5B ), and almost eliminated it at 300 μM.
The basal IP 1 accumulation, in which no drugs were administered, was 494 ± 91 disintegration per minute (DPM). ACh (10 μM) increased the IP 1 accumulation to 914 ± 56 DPM, and amitriptyline inhibited (P < 0.05) the ACh-induced IP 1 accumulation to 421 ± 51 DPM (Fig. 6 ). 
Discussion
The present results indicate that amitriptyline attenuates the contractile response to both exogenously applied and endogenously released ACh, the parasympathetic neurotransmitter that plays a central role in the regulation of airway smooth muscle tone in vivo.
However, the effective concentrations of amitriptyline in the present study were signifi cantly higher than clinically relevant concentrations (<1 μM). Thus, amitriptyline would not infl uence the contractile response to ACh through peripheral (i.e., direct and peripheral nerve) action on airway smooth muscle in the normal clinical setting. James et al. [16] observed the effects of tricyclic antidepressants on gastric smooth muscle contractility in guinea pigs, and found that amitriptyline reduced the contractions induced by ACh. Huang and Lau [17] reported that, in the rat isolated trachea, amitriptyline produced a shift to the right of the ACh concentrationcontraction curve without affecting the maximum contraction. The IC 50 value was 10.3 μM for inhibition of the submaximal contractile response to 1 μM ACh. This IC 50 value is similar to the value in our present study.
The most important mechanism for smooth muscle contraction is activation of the PI cascade as a result of interaction between a contractile molecule and a specifi c receptor coupled to phospholipase C (PLC). Specifi cally, the majority of contractile agonists acts on G-protein-coupled receptors, and thereby activate PLC to hydrolyze the membrane phospholipid phosphatidylinositol 4, 5-bisphosphate (PIP 2 ) into IP 3 and diacylglycerol. IP 3 stimulates the sarcoplasmic reticulum to release Ca 2+ that in turn activates the Ca 2+ -calmodulin-MLCK pathway and initiates contraction (Fig. 7) , while diacylglycerol activates protein kinase C, possibly leading to an increase in myofi lament Ca , is normally observed in the contractile response to receptor agonists. In previous studies with isolated human mesenteric arteries [18] , human vas deferens [19] , rabbit aorta [20] , and guinea-pig ileum [21, 22] , amitriptyline inhibited the contractile response to various receptor agonists, such as noradrenaline [18] [19] [20] , histamine [21] , and serotonin [22] . These results suggest that amitriptyline may inhibit activation of the PI cascade and thereby attenuate smooth muscle contractile activity. Indeed, in the present study, amitriptyline inhibited the AChinduced IP 1 accumulation, providing the fi rst direct evidence for the amitriptyline-induced inhibition of ACh-induced IP 3 production (i.e., ACh-activation of It is generally believed that, in humans, stimulation of β 2 -adrenergic receptors leads to airway relaxation through a direct action on airway smooth muscle and/or presynaptic inhibition of the vagus nerve [23] [24] [25] . Amitriptyline inhibits the reuptake of noradrenaline into nerve terminals in the brain [3] ; therefore, amitriptyline may also inhibit the reuptake of noradrenaline into nerve terminals in airway smooth muscle and thereby cause airway relaxation. However, treatment with guanethidine, which depletes noradrenaline storage vesicles in the nerve terminal [26] , did not inhibit, but enhanced the amitriptyline-induced airway relaxation. Thus, inhibition of the reuptake of noradrenaline into nerve terminals would not be involved in the amitriptyline-induced airway relaxation. The precise mechanisms behind the enhancement are unknown at present, and will require further research.
When agonists stimulate receptors on airway smooth muscle cell membranes, Rho, a small G-protein, activates Rho-kinase, which in turn inactivates myosin phosphatase (Fig. 7) . Inactivation of myosin phosphatase increases myosin light chain (MLC) phosphorylation, resulting in an increased contraction. Airway smooth muscle contraction occurs through the activation of receptors coupled with small G-proteins in canine, rabbit, and human airway smooth muscles in vitro, and involves the Rho-kinase pathway [27] [28] [29] [30] . It has been suggested that SPC causes vasoconstriction by activating the Rho-kinase pathway in cerebral, coronary, and pulmonary arteries [15, 31, 32] . In the present study, amitriptyline inhibited SPC-induced contraction, suggesting the possibility that amitriptyline inhibits Rho-kinase. However, amitriptyline also inhibited the calyculin A-induced contraction, i.e., the contraction caused by the inhibition of MLC phosphatase. Thus, the ability of amitriptyline to inhibit the SPC-induced contraction could be simply explained by its ability to inhibit the Ca 2+ -calmodulin-MLCK pathway. Nevertheless, we speculate that amitriptyline may inhibit Rhokinase, because the IC 50 value for inhibition of the SPC-induced contraction (98 μM) was signifi cantly lower than that for inhibition of the calyculin A-induced contraction (256 μM). Further research-including the direct measurement of Rho-kinase activity-is required to clarify this issue.
In conclusion, amitriptyline attenuates smooth muscle reactivity at supraclinical concentrations (≥1 μM). The attenuated response to ACh brought about by amitriptyline is presumably due, at least in part, to the inhibition of PI metabolism. The ability of amitriptyline to inhibit calyculin A-induced contraction suggests that amitriptyline also inhibits the Ca 2+ -calmodulin-MLCK pathway independently of its inhibition of PI metabolism. Finally, the difference between the IC 50 values for the SPC-induced contraction and the calyculin Ainduced contraction suggests that amitriptyline may also inhibit the Rho-kinase pathway. 
